Discover Community Create You

Loading publication...

Noodle always counts identifier-free feature events for service operation. With your permission, Google Analytics can also estimate audience and engagement. Search text, publication identifiers, cookies, IP addresses and browser fingerprints are never included in Noodle's first-party event counters.

Privacy details

Article

Proteogenomic Identification and Analysis of KIF5B as a Prognostic Signature for Hepatocellular Carcinoma

9 Sept 2024

Abstract excerpt

BACKGROUND: Metabolic disorders are significant risk factors for liver cancer, particularly Hepatocellular Carcinoma (HCC). However, the molecular genetic basis of metabolic reprogramming in the liver remains largely uncertain. OBJECTIVE: This study aimed to investigate some novel prognostic biomarkers in HCC by using proteogenomic and transcriptomic analysis and explore the potential role of specific prognostic...

Read the complete abstract on PubMed

Topics

Share this publication in a Topic to start or enrich a Post.

Share to Cancer, Hypoxia, and Metabolism
Share to Cancer, Lipids, and Metabolism
Share to Ferroptosis and cancer prognosis

Methodology Data sources Editorial policy Privacy About Contact Helena Bioinformatics

Source

Identifiers

PMID: 39248070
DOI: 10.2174/0115665232308821240826075513

Provenance

PubMed metadata and Literature Corpus relationships. Corpus snapshot updated 7 Sept 2026.

Related research

Semantic proximity does not establish scientific evidence.

Research trail→

Click a neighbor to travelStep 1 · 12 closest

Proteogenomic Identification and Analysis of KIF5B as a Prognostic Signature for Hepatocellular CarcinomaPMID 39248070Read ↗

New biomarkers and therapeutic targets of human liver cancer: Transcriptomic findingsSemantic proximity Read ↗

Key genes associated with non-alcoholic fatty liver disease and hepatocellular carcinoma with metabolic risk factorsSemantic proximity Read ↗

Identification and Validation of a Novel Metabolism‑Related Prognostic Signature in Hepatocellular CarcinomaSemantic proximity Read ↗

Construction and Validation of a Metabolic Reprogramming Related Prognostic Model for Hepatocellular CarcinomaSemantic proximity Read ↗

Development and validation of a CTNNB1-associated metabolic prognostic model for hepatocellular carcinoma.Semantic proximity Read ↗

PFKFB4 Drives the Oncogenicity in TP53-Mutated Hepatocellular Carcinoma in a Phosphatase-Dependent MannerSemantic proximity Read ↗

A Novel Nomogram Based on Lipid Metabolism-related Risk Gene Expression Can Better Predict Overall Survival for Hepatocellular CarcinomaSemantic proximity Read ↗

Identification of a novel metabolism‑related prognostic signature in hepatocellular carcinoma through bioinformatics analysis and validation through experimental studiesSemantic proximity Read ↗

Biomarker Panels Associated with Diagnosis and Overall Survival in Hepatocellular Carcinoma Revealed from Protein-Protein and mRNA-miRNA Interaction NetworksSemantic proximity Read ↗

Glycolysis-related gene expression profiling serves as a novel prognosis risk predictor for human hepatocellular carcinomaSemantic proximity Read ↗

Multiomics analysis reveals metabolic subtypes and identifies diacylglycerol kinase α (DGKA) as a potential therapeutic target for intrahepatic cholangiocarcinomaSemantic proximity Read ↗

FKBP10 as a Prognostic Biomarker and Therapeutic Target in Hepatocellular CarcinomaSemantic proximity Read ↗

⌁Select a neighboring publication to make it the new centre.